secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2023-02-28T23:59:59+00:00
Accession:  0000950170-23-005092
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences implements 1-for-40 reverse stock split effective March 1, 2023
--------------------------------------------------------------------------------

- Reverse stock split of common stock at 1:40 ratio, effective 12:01 a.m. ET on March 1, 2023.
- No fractional shares; odd shares rounded up to the next whole number.
- Authorized shares remain 150,000,000; par value unchanged at $0.001 per share.
- Stockholders approved split range (1:10 to 1:40) at Feb 15, 2023 special meeting; board selected 1:40.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023005092/0000950170-23-005092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023005092/rkda-20230227.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-005092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer